148 related articles for article (PubMed ID: 23270655)
1. Benefits of continuous subcutaneous insulin infusion on quality of life.
Lukács A; Kiss-Tóth E; Varga B; Soós A; Takác P; Barkai L
Int J Technol Assess Health Care; 2013 Jan; 29(1):48-52. PubMed ID: 23270655
[TBL] [Abstract][Full Text] [Related]
2. Quality of life in Danish children and adolescents with type 1 diabetes treated with continuous subcutaneous insulin infusion or multiple daily injections.
Birkebaek NH; Kristensen LJ; Mose AH; Thastum M;
Diabetes Res Clin Pract; 2014 Dec; 106(3):474-80. PubMed ID: 25451903
[TBL] [Abstract][Full Text] [Related]
3. [Benefits of continuous subcutaneous insulin infusion in children with type 1 diabetes mellitus].
Hasselmann C; Bonnemaison E; Faure N; Mercat I; Bouillo Pépin-Donat M; Magontier N; Chantepie A; Labarthe F
Arch Pediatr; 2012 Jun; 19(6):593-8. PubMed ID: 22584198
[TBL] [Abstract][Full Text] [Related]
4. Benefits of continuous subcutaneous insulin infusion in type 1 diabetes previously treated with multiple daily injections with once-daily glargine and pre-meal analogues.
Torres I; Ortego J; Valencia I; García-Palacios MV; Aguilar-Diosdado M
Exp Clin Endocrinol Diabetes; 2009 Sep; 117(8):378-85. PubMed ID: 19629931
[TBL] [Abstract][Full Text] [Related]
5. Health-related quality of life and treatment preferences in adolescents with type 1 diabetes. The VIPKIDS study.
Cherubini V; Gesuita R; Bonfanti R; Franzese A; Frongia AP; Iafusco D; Iannilli A; Lombardo F; Rabbone I; Sabbion A; Salvatoni A; Scaramuzza A; Schiaffini R; Sulli N; Toni S; Tumini S; Mosca A; Carle F;
Acta Diabetol; 2014 Feb; 51(1):43-51. PubMed ID: 23508374
[TBL] [Abstract][Full Text] [Related]
6. Continuous subcutaneous insulin infusion benefits quality of life in preschool-age children with type 1 diabetes mellitus.
Opipari-Arrigan L; Fredericks EM; Burkhart N; Dale L; Hodge M; Foster C
Pediatr Diabetes; 2007 Dec; 8(6):377-83. PubMed ID: 18036064
[TBL] [Abstract][Full Text] [Related]
7. Pregnancy outcome and glycemic control in women with type 1 diabetes: a retrospective comparison between CSII and MDI treatment.
Talaviya PA; Saboo BD; Joshi SR; Padhiyar JN; Chandarana HK; Shah SJ; Vyas CK; Shah AN
Diabetes Metab Syndr; 2013; 7(2):68-71. PubMed ID: 23680243
[TBL] [Abstract][Full Text] [Related]
8. Quality of life and treatment satisfaction in adults with Type 1 diabetes: a comparison between continuous subcutaneous insulin infusion and multiple daily injections.
; Nicolucci A; Maione A; Franciosi M; Amoretti R; Busetto E; Capani F; Bruttomesso D; Di Bartolo P; Girelli A; Leonetti F; Morviducci L; Ponzi P; Vitacolonna E
Diabet Med; 2008 Feb; 25(2):213-20. PubMed ID: 18201210
[TBL] [Abstract][Full Text] [Related]
9. Long-term benefits of continuous subcutaneous insulin infusion in children with Type 1 diabetes: a 4-year follow-up.
Sulli N; Shashaj B
Diabet Med; 2006 Aug; 23(8):900-6. PubMed ID: 16911629
[TBL] [Abstract][Full Text] [Related]
10. Insulin pump treatment; increasing prevalence, and predictors for better metabolic outcome in Danish children and adolescents with type 1 diabetes.
Olsen B; Johannesen J; Fredheim S; Svensson J;
Pediatr Diabetes; 2015 Jun; 16(4):256-62. PubMed ID: 25082292
[TBL] [Abstract][Full Text] [Related]
11. [Continuous subcutaneous insulin infusion].
Balsa AM; Neves C; Alves M; Pereira M; Carvalho D; Medina JL
Acta Med Port; 2011 Dec; 24 Suppl 2():147-56. PubMed ID: 22849898
[TBL] [Abstract][Full Text] [Related]
12. [Satisfaction and quality of life evaluation in patients with type 1 diabetes mellitus treated using continuous subcutaneous insulin infusion compared with multiple daily injections].
Lozano-Serrano M; García-Seco JA; García-Seco F; Lozano-Hernández MC; Seco-Segura ÁM; Moreno-Fernández J; Muñoz-Cazallas PA; Ferreiro-Vicario C; Sánchez-Covisa MA
Enferm Clin; 2013; 23(3):96-102. PubMed ID: 23755944
[TBL] [Abstract][Full Text] [Related]
13. Benefits of continuous subcutaneous insulin infusion (CSII) therapy in preschool children.
Levy-Shraga Y; Lerner-Geva L; Modan-Moses D; Graph-Barel C; Mazor-Aronovitch K; Boyko V; Pinhas-Hamiel O
Exp Clin Endocrinol Diabetes; 2013 Apr; 121(4):225-9. PubMed ID: 23329580
[TBL] [Abstract][Full Text] [Related]
14. Type 1 diabetes control and pregnancy outcomes in women treated with continuous subcutaneous insulin infusion (CSII) or with insulin glargine and multiple daily injections of rapid-acting insulin analogues (glargine-MDI).
Bruttomesso D; Bonomo M; Costa S; Dal Pos M; Di Cianni G; Pellicano F; Vitacolonna E; Dodesini AR; Tonutti L; Lapolla A; Di Benedetto A; Torlone E;
Diabetes Metab; 2011 Nov; 37(5):426-31. PubMed ID: 21474360
[TBL] [Abstract][Full Text] [Related]
15. Continuous subcutaneous insulin infusion preserves axonal function in type 1 diabetes mellitus.
Kwai N; Arnold R; Poynten AM; Lin CS; Kiernan MC; Krishnan AV
Diabetes Metab Res Rev; 2015 Feb; 31(2):175-82. PubMed ID: 25066412
[TBL] [Abstract][Full Text] [Related]
16. Factors influencing the diabetes-specific health-related quality of life in children and adolescents with type 1 diabetes mellitus.
Lukács A; Varga B; Kiss-Tóth E; Soós A; Barkai L
J Child Health Care; 2014 Sep; 18(3):253-60. PubMed ID: 23749254
[TBL] [Abstract][Full Text] [Related]
17. Continuous subcutaneous insulin infusion (CSII) versus multiple daily injections (MDI) of rapid-acting insulin analogues and detemir in type 1 diabetic (T1D) pregnant women.
Mello G; Biagioni S; Ottanelli S; Nardini C; Tredici Z; Serena C; Marchi L; Mecacci F
J Matern Fetal Neonatal Med; 2015 Feb; 28(3):276-80. PubMed ID: 24724804
[TBL] [Abstract][Full Text] [Related]
18. Use of rapid-acting insulin analogues in the treatment of patients with type 1 and type 2 diabetes mellitus: insulin pump therapy versus multiple daily injections.
Bode BW
Clin Ther; 2007; 29 Suppl D():S135-44. PubMed ID: 18191065
[TBL] [Abstract][Full Text] [Related]
19. Continuous subcutaneous insulin infusion versus multiple daily injections in pregnant women with type 1 diabetes.
González-Romero S; González-Molero I; Fernández-Abellán M; Domínguez-López ME; Ruiz-de-Adana S; Olveira G; Soriguer F
Diabetes Technol Ther; 2010 Apr; 12(4):263-9. PubMed ID: 20210564
[TBL] [Abstract][Full Text] [Related]
20. In Type 1 diabetic patients with good glycaemic control, blood glucose variability is lower during continuous subcutaneous insulin infusion than during multiple daily injections with insulin glargine.
Bruttomesso D; Crazzolara D; Maran A; Costa S; Dal Pos M; Girelli A; Lepore G; Aragona M; Iori E; Valentini U; Del Prato S; Tiengo A; Buhr A; Trevisan R; Baritussio A
Diabet Med; 2008 Mar; 25(3):326-32. PubMed ID: 18307459
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
